Today: 28 February 2026
Subscribe
Browse Category

ASX:WES 10 January 2026 - 25 February 2026

Wesfarmers share price drops as ASX hits record; dividend clock and filings in focus

Wesfarmers share price drops as ASX hits record; dividend clock and filings in focus

Wesfarmers shares fell 1.36% to A$79.99 Wednesday, underperforming as the S&P/ASX 200 hit a record high. The company set February 25 as the record date for its 102-cent fully franked interim dividend, payable March 31. Director equity-plan conversions totaling 969 shares were disclosed in filings. Australia’s core inflation remained above target in January, fueling rate-hike speculation.
25 February 2026
··
Wesfarmers shares wobble after profit beat, as dividend date and consumer demand come into view

Wesfarmers shares wobble after profit beat, as dividend date and consumer demand come into view

Wesfarmers shares fell 0.3% to A$83.99 on Friday, extending a 5.6% drop after its results. The company reported first-half net profit of A$1.6 billion, up 9.3%, and raised its interim dividend to A$1.02 a share. Shares go ex-dividend Feb. 24, with payment due March 31. CEO Rob Scott warned of uneven consumer spending and flagged price cuts funded by productivity and AI.
20 February 2026
···
Wesfarmers share price: two dates that could move ASX:WES next week

Wesfarmers share price: two dates that could move ASX:WES next week

Wesfarmers shares closed up 0.3% at A$83.36 on Friday, outperforming a 0.65% drop in the S&P/ASX 200. Attention turns to the Reserve Bank of Australia’s Feb. 3 rate decision, with major banks tipping a hike after strong inflation data. Mortgage-stress groups warn household budgets are under pressure. Wesfarmers will report half-year results on Feb. 19.
31 January 2026
·
Wesfarmers walks away from a $400m Priceline rescue — and now the Infinity pharmacies are up for grabs

Wesfarmers walks away from a $400m Priceline rescue — and now the Infinity pharmacies are up for grabs

Wesfarmers has withdrawn from efforts to rescue Infinity Pharmacy Group, leaving 54 Priceline stores in receivership with debts over A$400 million. Receivers are keeping more than 50 stores open while creditors weigh options. Chemist Warehouse and Genesis Capital have shown interest in acquiring the distressed pharmacy network. Major banks and Wesfarmers-owned API are among the largest creditors.
20 January 2026
1 2 3
Go toTop